Canine cancer insights—for both sides of the leash
​We operate FidoCure, a precision oncology platform that treats cancer in dogs and builds a real‑world evidence engine for oncology—rooted in the One Health concept.
What We Do
Precision Oncology for a One Health World
The One Health Company brings human‑grade precision medicine to canine cancer and turns every case into structured data. By combining genomic testing, targeted therapies, and outcomes at scale, we support better decisions in veterinary oncology and generate insights with direct relevance to human cancer research.
Why One Health
Why Dogs, Why Now
Dogs and humans share many of the same cancers and live in the same environments. The One Health framework recognizes that oncology should reflect that reality. Treating naturally occurring cancer in dogs with modern precision tools produces clinically relevant, ethically grounded data that can accelerate progress in both veterinary and human medicine.
The One Health Company
Who We Are
The One Health Company was founded to bridge human and veterinary oncology through a single, integrated precision medicine platform. Drawing on experience in animal health, cancer research, and data science, we built FidoCure to deliver personalized care to dogs with cancer while generating a unique cross‑species cancer dataset. Our work is designed for partners who see One Health not as a slogan, but as an operating model for the next generation of oncology.
We collaborate with leading clinicians, researchers, and industry partners who are building the future of cancer care across species.